Is metoprolol (Toprol) dialyzable in patients with impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metoprolol (Toprol) Dialyzability

Metoprolol is only slightly dialyzable and should not be relied upon for removal by hemodialysis in most clinical situations. 1

Dialyzability Classification

The EXTRIP workgroup systematically reviewed beta-blockers and classified metoprolol as "slightly dialyzable" by intermittent hemodialysis, placing it in a middle category between extensively dialyzable drugs (like atenolol) and non-dialyzable drugs (like propranolol or carvedilol). 1

Clinical Evidence of Dialytic Clearance

Recent pharmacokinetic studies using modern high-flux hemodialysis membranes demonstrate measurable but limited removal:

  • Recovery clearance method: 87 ml/min dialytic clearance 2
  • Arterial-venous difference method: 114 ml/min dialytic clearance 2
  • These clearance values are substantially lower than atenolol (167 ml/min) but higher than carvedilol (essentially 0%) 2

Pharmacokinetic Properties Affecting Dialyzability

Metoprolol's limited dialyzability is explained by its pharmacokinetic characteristics:

  • Primary elimination: Hepatic metabolism via CYP2D6, not renal excretion 3, 4
  • Renal excretion of unchanged drug: Less than 10% in extensive metabolizers (up to 30-40% in poor CYP2D6 metabolizers) 3
  • Oral bioavailability: Approximately 50% due to first-pass metabolism 3
  • Elimination half-life: 3-4 hours in normal metabolizers (7-9 hours in poor metabolizers) 3

Clinical Implications for Dialysis Patients

Dosing Considerations

  • No routine dose adjustment required for patients with renal impairment on hemodialysis, as elimination is primarily hepatic 3
  • The systemic availability and half-life do not differ clinically significantly between patients with renal failure and those with normal renal function 3

Poisoning/Overdose Context

  • Hemodialysis is not recommended as a primary treatment for metoprolol poisoning due to its slight dialyzability 1
  • The EXTRIP workgroup did not develop specific recommendations for metoprolol in poisoning cases due to insufficient clinical data, despite its classification as slightly dialyzable 1

Metabolite Considerations

  • Active metabolites of metoprolol may be partially removed by dialysis, which could explain improved glucose response to glucagon after dialysis in some studies 5
  • This metabolite removal may have clinical relevance for glucose metabolism in dialysis patients 5

Key Clinical Pitfall

Do not assume metoprolol requires supplemental dosing after hemodialysis. Unlike atenolol (which is extensively dialyzable and requires post-dialysis supplementation), metoprolol's hepatic metabolism means dialysis has minimal impact on total drug clearance. 3, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.